Possible correction of defective polymorphonuclear cell functions in type-2 diabetes mellitus by met-enkephalin
- PMID: 3037972
- DOI: 10.1111/j.1749-6632.1987.tb35761.x
Possible correction of defective polymorphonuclear cell functions in type-2 diabetes mellitus by met-enkephalin
Abstract
In vitro pretreatment with Met-Enk of human PMNLs obtained from patients suffering from type-2 diabetes mellitus resulted in the normalization of the ROS generating system. It is assumed that Met-Enk has a modulating effect on the arachidonic acid metabolism, with a consecutive increase of the LTB4 release.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
